|
Schwartz, S. (2009). Insomnie et addiction, un même combat : une étude menée à l'UNIGE révèle un lien surprenant entre la régulation du sommeil et les mécanismes d'addiction. Genève: Université de Genève.
Keywords: addictive behavior; drug
|
|
|
Comité de la Conférence de la convention CIIS. (2007). Directives-cadre CIIS relatives aux exigences de qualité. Berne: Conférence des directeurs cantonaux des affaires sociales (CDAS).
Keywords: government and politics; social services; legal regulation; cooperation; Switzerland
|
|
|
Notari, L., & Delgrande Jordan, M. (2012). La santé des personnes âgées de 60 ans et plus vivant dans les ménages privés : une analyse des données de l'enquête suisse sur la santé 2007. Lausanne: Addiction Suisse.
Keywords: old age; health; public health; mental health; survey; alcohol; smoking; multiple drug use; social support; general practitioner; Switzerland; report
|
|
|
Huber, M., Weber, R., Oppliger, R., Vernazza, P., Schmid, P., Schönbucher, P., et al. (2005). Interferon-alpha2a plus ribavirin 1000/1200 mg versus interferon-alpha2a plus ribavirin 600 mg for treatment of chronic hepatitis C among patients in opiate substitution programs : an open-label randomized multicenter trial : Korrekturexemplar. Infection, 33(1), 93–97.
Abstract: Background: Many intravenous opiate users are infected with hepatitis C virus (HCV) but few are treated. Although this complies with various guidelines, virtually no published evidence supports such a recommendation. Patients and Methods: In a multicenter study, HCV-infected patients in opiate maintenance treatment programs received interferon plus high- or low-dose ribavirin (1000/1200 mg or 600 mg). HIV-coinfected patients were not included. Endpoints were feasibility, efficacy, side effects, and reasons for dropout. Results: Of the 420 patients who tested positive for HCV, 27 (6%) were enrolled; 393 (94%) either failed to meet the inclusion criteria or refused treatment. Virologic end-of-treatment response was achieved in 12/27 patients, and sustained response in 13/27 (48%). Response depended on viral genotype, not ribavirin dose. The two doses of ribavirin did not differ in their side effects. Conclusion: In a small fraction of HCV-infected intravenous drug users in an opiate maintenance treatment program, antiviral therapy was feasible, safe and effective. The success rate was comparable to that achieved in controlled studies that excluded drug users.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
Wälthy, P., & Zweifel, P. (2004). Daten zum Artikel “250 000 Raver auf Koks, Cannabis, Ecstasy und Co”. Zürich: 20 Minuten.
Keywords: AOD consumption; AOD induced risk; cannabis; ecstasy; cocaine; nightlife; Zurich; Switzerland; study; statistical data
|
|
|
Huber, M., Oppliger, R., Vernazza, P., Schönbucher, P., Bertisch, B., Meili, D., et al. (2002). Therapie der Chronischen Hepatitis C in offiziellen Opiat Substitutionsprogrammen : Interferon alfa 2a in Kombination mit Ribavirin in hoher oder niedriger Dosis : eine offene, randomisierte Multizenterstudie. Suchtmedizin in Forschung und Praxis, 4(2), 84–85.
|
|
|
Schaaf, S. (2006). Substitutionsbehandlung im Rahmen stationärer ausstiegsorientierter Suchttherapie in der Schweiz : Literaturüberblick : Bestandesaufnahme Klientendaten 2003/2004 : Institutionsbefragung zur Substitutionspraxis in stationärer Therapie. Zürich: Institut für Sucht- und Gesundheitsforschung (ISGF).
Keywords: treatment and maintenance; inpatient care
|
|
|
Peter, R. (2005). Kostenvergleich zwischen Therapie und Substitutionsbehandlungen : BM-Arbeit.
Keywords: treatment and maintenance; inpatient care
|
|
|
Ledoux, Y. (1987). Le devenir des patients du centre d'accueil pour usagers de la drogue C.A.T.S. : rapport final. Bruxelles: Université libre de Bruxelles, Centre de sociologie de la santé.
Keywords: treatment and maintenance; inpatient care; Belgium; Brussels
|
|
|
World Health Organization. (1995). Consultation on WHO drug substitution project. In Consultation on WHO drug substitution project. Geneva: World Health Organization (WHO).
Keywords: treatment and maintenance; outpatient care
|
|